- Home
- HBI vs IDYA Comparison
HBI vs IDYA Comparison
Compare HBI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBI
- IDYA
- Stock Information
- Founded
- HBI 1901
- IDYA 2015
- Country
- HBI United States
- IDYA United States
- Employees
- HBI N/A
- IDYA N/A
- Industry
- HBI Clothing/Shoe/Accessory Stores
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HBI Consumer Discretionary
- IDYA Health Care
- Exchange
- HBI Nasdaq
- IDYA Nasdaq
- Market Cap
- HBI 2.5B
- IDYA 2.6B
- IPO Year
- HBI 2006
- IDYA 2019
- Fundamental
- Price
- HBI $8.19
- IDYA $26.60
- Analyst Decision
- HBI Hold
- IDYA Strong Buy
- Analyst Count
- HBI 5
- IDYA 12
- Target Price
- HBI $6.00
- IDYA $53.67
- AVG Volume (30 Days)
- HBI 6.5M
- IDYA 769.7K
- Earning Date
- HBI 11-07-2024
- IDYA 11-04-2024
- Dividend Yield
- HBI N/A
- IDYA N/A
- EPS Growth
- HBI N/A
- IDYA N/A
- EPS
- HBI N/A
- IDYA N/A
- Revenue
- HBI $5,466,904,000.00
- IDYA $3,922,000.00
- Revenue This Year
- HBI N/A
- IDYA N/A
- Revenue Next Year
- HBI $0.22
- IDYA $158.10
- P/E Ratio
- HBI N/A
- IDYA N/A
- Revenue Growth
- HBI 25.57
- IDYA N/A
- 52 Week Low
- HBI $3.58
- IDYA $25.20
- 52 Week High
- HBI $8.70
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- HBI 61.17
- IDYA 37.36
- Support Level
- HBI $6.98
- IDYA $25.62
- Resistance Level
- HBI $8.60
- IDYA $32.67
- Average True Range (ATR)
- HBI 0.41
- IDYA 1.50
- MACD
- HBI 0.05
- IDYA -0.36
- Stochastic Oscillator
- HBI 70.06
- IDYA 18.74
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces more than 70% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.